Daiichi Sankyo Obtains Approval in Japan for Additional Indication and Dosage for Ovisot® for Injection in Diagnosis of Vasospastic Angina – Media & Investors .
Tokyo, Japan (August 25, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has obtained approval in Japan for an additional indication and dosage for Ovisot® for injection (acetylcholine chloride) for induction of coronary spasm in spasm provocation testing during angiography. Coronary spasm provocation tests performed by an intracoronary injection of acetylcholine chloride have been confirmed to be a valuable option for diagnosis of vasospastic angina which is a condition that can lead to acute myocardial infarction and even sudden death. Daiichi Sankyo
http://www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/006688.html